The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -16.20%.However, over the last six months, we can see a stronger performance of -74.06%. Over the last 30 days, the price of BCAB has fallen by 32.71%. And in the last five days, it has surged by 43.18%.
BioAtla Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.53 on 05/01/24 and the lowest value was $0.24 on 03/04/25.
52-week price history of BCAB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. BioAtla Inc’s current trading price is -85.97% away from its 52-week high, while its distance from the 52-week low is 106.42%. The stock’s price range during this period has varied between$0.24 and $3.53. The BioAtla Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.12 million for the day, a figure considerably higher than their average daily volume of 0.72 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
BioAtla Inc (BCAB) has experienced a quarterly rise of 2.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 28.94M and boasts a workforce of 76 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5602, with a change in price of -1.1746. Similarly, BioAtla Inc recorded 887,601 in trading volume during the last 100 days, posting a change of -70.34%.
BCAB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BCAB stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.00.
BCAB Stock Stochastic Average
BioAtla Inc’s raw stochastic average for the past 50 days is presently 89.24%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 88.43%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 84.87% and 87.55%, respectively.
